Clinical

Dataset Information

0

Aflibercept and 5-FU vs. FOLFOX as 1st Line Treatment for Elderly or Frail Elderly Patients With Met. Colorectal Cancer


ABSTRACT: This is a controlled, open-label, randomized phase- II trial (1:1 randomization) investigating 5-FU + aflibercept and 5-FU + oxaliplatin in elderly and frail elderly patients with mCRC scheduled to receive first line treatment.

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Cancer,Colorectal Neoplasms,Colorectal Cancer Metastatic

PROVIDER: 2273321 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2023-02-04 | GSE144304 | GEO
2013-09-01 | E-GEOD-50519 | biostudies-arrayexpress
| 2417793 | ecrin-mdr-crc
| 2213354 | ecrin-mdr-crc
2013-09-01 | GSE50519 | GEO
| 2089319 | ecrin-mdr-crc
| 2336924 | ecrin-mdr-crc
| 2254063 | ecrin-mdr-crc
| 2536279 | ecrin-mdr-crc
2019-10-01 | GSE124956 | GEO